Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.7 |
mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.7 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.061 | 0.7 |